TOTIENT
Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics. It uses machine learning and immunoinformatics technology to pull critical insights from large, complex datasets, to quickly and accurately assemble the most potent antibody candidates. The unique applicability of the Totient platform allows the company to remain flexible and develop therapeutics for cancer, autoimmune disease, infections, and viruses. It was founded in 2017 and is based in Cambridge, Massachusetts.
TOTIENT
Industry:
Artificial Intelligence Biotechnology Life Science Machine Learning
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.totient.bio
Total Employee:
11+
Status:
Active
Contact:
(617) 221-8986
Total Funding:
10 M USD
Technology used in webpage:
Amazon Google Apps For Business Amazon Route 53 Amazon CloudFront
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
CytoVale
Categorized is a medical technology company that revolutionizes diagnostics using cell mechanics and machine learning.
Dyno Therapeutics
Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.
Kebotix
Kebotix is a high-tech materials discovery and production company that reinvent the discovery of new materials using AI.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Protai
Protai is an AI-powered drug discovery startup.
ReviveMed
ReviveMed is a precision-medicine platform that leverages the data from small molecules or metabolites.
Current Employees Featured
Deniz Kural CEO & Founder @ Totient
CEO & Founder
2017-03-01
Founder
Investors List
CerraCap Ventures
CerraCap Ventures investment in Venture Round - Totient
Tachyon Ventures
Tachyon Ventures investment in Seed Round - Totient
Viva Biotech
Viva Biotech investment in Seed Round - Totient
Andrew Izyumov
Andrew Izyumov investment in Seed Round - Totient
Sands Capital Ventures
Sands Capital Ventures investment in Seed Round - Totient
Kaitai Capital
Kaitai Capital investment in Seed Round - Totient
Jonathan Milner
Jonathan Milner investment in Seed Round - Totient
Helicase Venture
Helicase Venture investment in Seed Round - Totient
Tau Ventures
Tau Ventures investment in Seed Round - Totient
Mission BioCapital
Mission BioCapital investment in Seed Round - Totient
Official Site Inspections
http://www.totient.bio
- Host name: 172.67.152.111
- IP address: 172.67.152.111
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Totient"
Totient - Crunchbase Company Profile & Funding
Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody …See details»
Totient 2025 Company Profile: Valuation, Investors, …
Information on acquisition, funding, cap tables, investors, and executives for Totient. Use the PitchBook Platform to explore the full profile.See details»
totient.bio: Revenue, Worth, Valuation & Competitors 2025
About totient.bio totient.bio is a Biotech related company founded in 2017 and based in Cambridge with 5 employees an estimated revenue of $775K, and. It has 10 competitors …See details»
Totient - Company info. interviews, news
Aug 18, 2022 Totient is an AI-driven biotechnology company leveraging tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics. Totient reconstructs antibodies …See details»
Totient - Products, Competitors, Financials, Employees, …
About Totient Totient is an early-stage immuno-oncology company. It develops therapies that translate insights into natural immune responses and cancer heterogeneity into meaningful …See details»
Totient - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 9, 2025 Totient - Developer of a drug discovery platform for cancer and autoimmune disease by using artificial intelligence. Raised a total funding of $10.5M over 4 rounds from 15 …See details»
Totient Company Profile - Office Locations, Competitors ... - Craft
See insights on Totient including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Totient - Crustdata Company Profile, Funding and Growth
Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody …See details»
Totient, a Viva Biotech Portfolio Company, is Acquired …
VANCOUVER, Wash., June 14, 2021 --- AbSci, the synthetic biology company unlocking the potential of proteins as next-generation therapeutics, today announced the acquisition of Totient, a discovery company invested and …See details»
Totient, a Viva Biotech Portfolio Company, has been Acquired
The combination of the Totient technology with AbSci's platform provides the framework and data to enable in silico targeted drug design, and ultimately achieve the goals of making the best …See details»
Totient, Inc. Company Profile | Cambridge, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Totient, Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Totient - Tech Company Profile - Gaebler.com Venture Capital …
Totient is an AI-driven biotechnology company leveraging tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody …See details»
Totient - VentureRadar
Genesis Therapeutics is Unifying AI and Biotech. We're pairing proven drug developers with the industry's most advanced small molecule discovery platform, to accelerate and optimize the …See details»
Totient, Inc.:Company Profile & Technical Research,Competitor …
What kind of company is Totient, Inc.? Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and …See details»
Totient, a Viva Biotech Portfolio Company, has been Acquired by …
Jun 16, 2021 Totient, a Viva Biotech Portfolio Company, has been Acquired by AbSci The combination of the Totient technology with AbSci's platform provides the framework and data …See details»
Totient - Viva BioInnovator
Totient enables next generation cell therapies and other therapeutic modalities by building the largest library of human-derived antibodies to novel and known tissue-specific antigens. The …See details»
Totient – Funding, Valuation, Investors, News
Essential stats, news, real-time insights on Totient. Connect with decision makers, founders, investors. Explore valuation, funding rounds, reviews.See details»
Totient | VentureRadar
Xellar is a Wet-AI, Artificial Intelligence and machine learning combined with large-scale wet-lab experiments, biotech company tackling the most challenging problem in modern drug …See details»
Totient Comes Out of Stealth with Novel COVID-19 Program and …
CAMBRIDGE, Mass., Sept. 10, 2020 /PRNewswire/ -- Today, Totient, an AI-driven drug discovery company based in Cambridge, MA, emerged from stealth with $10M in seed funding and a …See details»
Totient, a Viva Biotech Portfolio Company, Achieves the …
VANCOUVER, Wash., June 14, 2021 --- AbSci, the synthetic biology company unlocking the potential of proteins as next-generation therapeutics, today announced the acquisition of …See details»